SG11202011866QA - Method of treatment with histamine-3 receptor inverse agonist - Google Patents
Method of treatment with histamine-3 receptor inverse agonistInfo
- Publication number
- SG11202011866QA SG11202011866QA SG11202011866QA SG11202011866QA SG11202011866QA SG 11202011866Q A SG11202011866Q A SG 11202011866QA SG 11202011866Q A SG11202011866Q A SG 11202011866QA SG 11202011866Q A SG11202011866Q A SG 11202011866QA SG 11202011866Q A SG11202011866Q A SG 11202011866QA
- Authority
- SG
- Singapore
- Prior art keywords
- histamine
- treatment
- inverse agonist
- receptor inverse
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201841020498 | 2018-05-31 | ||
| PCT/IB2018/055769 WO2019229509A1 (en) | 2018-05-31 | 2018-08-01 | Method of treatment with histamine-3 receptor inverse agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202011866QA true SG11202011866QA (en) | 2020-12-30 |
Family
ID=63294392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202011866QA SG11202011866QA (en) | 2018-05-31 | 2018-08-01 | Method of treatment with histamine-3 receptor inverse agonist |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11622967B2 (en) |
| EP (1) | EP3806859A1 (en) |
| JP (1) | JP7074895B2 (en) |
| KR (1) | KR102639048B1 (en) |
| CN (1) | CN112367998B (en) |
| AU (1) | AU2018425507B2 (en) |
| BR (1) | BR112020024264A2 (en) |
| CA (1) | CA3101924A1 (en) |
| EA (1) | EA202092979A1 (en) |
| IL (1) | IL279045A (en) |
| MA (1) | MA52850A (en) |
| MX (1) | MX2020012912A (en) |
| SG (1) | SG11202011866QA (en) |
| WO (1) | WO2019229509A1 (en) |
| ZA (1) | ZA202007407B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022113008A1 (en) * | 2020-11-27 | 2022-06-02 | Richter Gedeon Nyrt. | Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder |
| CN116693446A (en) * | 2022-03-02 | 2023-09-05 | 杭州百诚医药科技股份有限公司 | Phenylurea derivative and medical application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1972914A (en) * | 2004-03-31 | 2007-05-30 | 詹森药业有限公司 | Non-imidazole heterocyclic compounds as histamine H3-receptor ligands |
| EP1717235A3 (en) * | 2005-04-29 | 2007-02-28 | Bioprojet | Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands |
| CN103443093B (en) * | 2011-02-23 | 2015-02-25 | 苏文生命科学有限公司 | Novel compounds as histamine H3 receptor ligands |
| CA2957494C (en) * | 2014-08-16 | 2018-08-28 | Suven Life Sciences Limited | Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acetamide dihydrochloride |
| ME03812B (en) * | 2016-08-18 | 2021-04-20 | Suven Life Sciences Ltd | Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors |
| JP6734469B2 (en) | 2016-08-18 | 2020-08-05 | スヴェン・ライフ・サイエンシーズ・リミテッドＳｕｖｅｎ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｉｍｉｔｅｄ | Three combinations of histamine-3 receptor inverse agonist, acetylcholinesterase inhibitor and NMDA receptor antagonist |
-
2018
- 2018-08-01 WO PCT/IB2018/055769 patent/WO2019229509A1/en active Application Filing
- 2018-08-01 KR KR1020207037968A patent/KR102639048B1/en active IP Right Grant
- 2018-08-01 MX MX2020012912A patent/MX2020012912A/en unknown
- 2018-08-01 BR BR112020024264-0A patent/BR112020024264A2/en unknown
- 2018-08-01 US US17/059,429 patent/US11622967B2/en active Active
- 2018-08-01 EP EP18758741.5A patent/EP3806859A1/en active Pending
- 2018-08-01 CA CA3101924A patent/CA3101924A1/en active Pending
- 2018-08-01 JP JP2020566825A patent/JP7074895B2/en active Active
- 2018-08-01 SG SG11202011866QA patent/SG11202011866QA/en unknown
- 2018-08-01 CN CN201880095289.6A patent/CN112367998B/en active Active
- 2018-08-01 AU AU2018425507A patent/AU2018425507B2/en active Active
- 2018-08-01 MA MA052850A patent/MA52850A/en unknown
- 2018-08-01 EA EA202092979A patent/EA202092979A1/en unknown
-
2020
- 2020-11-27 ZA ZA2020/07407A patent/ZA202007407B/en unknown
- 2020-11-29 IL IL279045A patent/IL279045A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3806859A1 (en) | 2021-04-21 |
| AU2018425507B2 (en) | 2022-02-17 |
| MX2020012912A (en) | 2021-05-27 |
| ZA202007407B (en) | 2023-06-28 |
| EA202092979A1 (en) | 2021-03-12 |
| KR20210014164A (en) | 2021-02-08 |
| MA52850A (en) | 2021-04-21 |
| AU2018425507A1 (en) | 2020-12-24 |
| KR102639048B1 (en) | 2024-02-22 |
| BR112020024264A2 (en) | 2021-02-23 |
| US20210213026A1 (en) | 2021-07-15 |
| WO2019229509A1 (en) | 2019-12-05 |
| JP7074895B2 (en) | 2022-05-24 |
| IL279045A (en) | 2021-01-31 |
| NZ770420A (en) | 2023-09-29 |
| JP2021526524A (en) | 2021-10-07 |
| CA3101924A1 (en) | 2019-12-05 |
| US11622967B2 (en) | 2023-04-11 |
| CN112367998B (en) | 2024-05-28 |
| CN112367998A (en) | 2021-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202005592QA (en) | Financing Methods and Apparatuses | |
| IL283362A (en) | Thrβ receptor agonist compound and preparation method and use thereof | |
| ZA201800087B (en) | Vibrating screening feeder and method of use | |
| HK1254815A1 (en) | Toilet apparatus and method of use | |
| IL270245B (en) | An apparatus and method for managing use of capabilities | |
| IL279045A (en) | Method of treatment with histamine-3 receptor inverse agonist | |
| SG11202011564RA (en) | Electroplating apparatus and electroplating method | |
| EP3345096A4 (en) | Method and apparatus for adaptive cache management | |
| SG11202106509UA (en) | Plating apparatus and plating method | |
| ZA202102970B (en) | Method and apparatuses for screening | |
| GB2571260B (en) | Method and related aspects for buffer management | |
| IL276053A (en) | Therapeutic-gard and method of use thereof | |
| GB201609000D0 (en) | Improved component for replacing pipes and method of use | |
| SG11202105877YA (en) | Method of treatment | |
| IL264406B (en) | Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors | |
| GB202001263D0 (en) | Construction apparatus and method of use thereof | |
| GB201708413D0 (en) | Incubator and method for use | |
| GB201801181D0 (en) | Method of use | |
| HUE064558T2 (en) | Treatment of pain with serotonin-3 receptor agonist | |
| GB2575017B (en) | Alignment Arrangement and Method of Alignment | |
| IL277901A (en) | Cleaning device and method of cleaning | |
| EP3849663C0 (en) | Pyrimidinyl-heteroaryloxy-naphthyl compounds and methods of use | |
| GB201820236D0 (en) | Method of treatment | |
| GB201820157D0 (en) | Method of treatment | |
| GB201816729D0 (en) | Apparatus and method for slipforming |